Study finds Pletal may prevent strokes
NEW YORK A drug used to treat muscle pain resulting from exercise may be able to prevent strokes more effectively than aspirin, according to published reports.
According to a trial in Japan, the Cilostazol Stroke Prevention Study II, patients who had suffered ischemic stroke who took the drug cilostazol had a chance of recurrence 26% lower than patients who took aspirin.
Funding for the study came from Otsuka Pharmaceutical, the original manufacturer of cilostazol, under the brand name Pletal. The drug is also available in generic form.